Long-term prostaglandin E1therapy in congenital heart defects
- 1 March 1984
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 3 (3), 838-843
- https://doi.org/10.1016/s0735-1097(84)80262-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Prostaglandin E1 infusion in newborns with hypoplastic left ventricle and aortic atresiaPediatric Cardiology, 1982
- Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.Circulation, 1981
- Long-term low-dose prostaglandin E1 administrationThe Journal of Pediatrics, 1980
- Role of prostaglandin E1 infusion in the management of transposition of the great arteriesThe American Journal of Cardiology, 1979
- Use of prostaglandin E1 in infants with d-transposition of the great arteries and intact ventricular septumThe American Journal of Cardiology, 1979
- Administration of prostaglandin E1 in neonates with critical congenital cardiac defectsThe Journal of Pediatrics, 1978
- The use of prostaglandin E1 in an infant with interruption of the aortic archThe Journal of Pediatrics, 1977
- PROSTAGLANDIN E1 FOR INTERRUPTED AORTIC ARCH IN THE NEONATEThe Lancet, 1976
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975